Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![sourabhwadhwa22 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1554483840043094017.png) Mr. Wadhwa [@sourabhwadhwa22](/creator/twitter/sourabhwadhwa22) on x XXX followers
Created: 2025-07-16 13:38:05 UTC

16th July Stocks Update:Part X

👉Dixon Technologies: News of buying a XX% stake in Kunshan Q Tech.

👉Biocon: Its arm Biocon Biologics received FDA approval for its insulin product, Kirsty, expanding its diabetes portfolio in the US.

👉Centrum Capital: Approved raising Rs XXXXX crore through equity.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945478042496762060/c:line.svg)

**Related Topics**
[rs](/topic/rs)
[dixon technologies](/topic/dixon-technologies)
[stocks](/topic/stocks)

[Post Link](https://x.com/sourabhwadhwa22/status/1945478042496762060)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

sourabhwadhwa22 Avatar Mr. Wadhwa @sourabhwadhwa22 on x XXX followers Created: 2025-07-16 13:38:05 UTC

16th July Stocks Update:Part X

👉Dixon Technologies: News of buying a XX% stake in Kunshan Q Tech.

👉Biocon: Its arm Biocon Biologics received FDA approval for its insulin product, Kirsty, expanding its diabetes portfolio in the US.

👉Centrum Capital: Approved raising Rs XXXXX crore through equity.

XXX engagements

Engagements Line Chart

Related Topics rs dixon technologies stocks

Post Link

post/tweet::1945478042496762060
/post/tweet::1945478042496762060